Artera’s prostate biopsy and breast cancer assays receive CE mark

​Artera has secured CE marking under the EU IVDR for its ArteraAI Prostate Biopsy and Breast Cancer assays, expanding the company’s global reach.

The post Artera’s prostate biopsy and breast cancer assays receive CE mark appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.